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Toward the Twenty-First Century: Lessons
from Lead and Lessons Yet To Learn
by Ellen K. Silbergeld*
Aconsiderationofrecentresearchon lead isinstructivefordevelopingresearchstrategies inenvironmen-
tal toxicology. Lead research has demonstrated fruitful interactions between clinical and basic science.
Thus, whileepidemiological studieshavesuggestedthatcentralnervoussystem(CNS)effectsinchildrenare
observed at the lowest increments of lead exposure, basic research has elucidated some ofthe molecular
eventsthatunderlythis lackofthreshold attheneuronallevel. Similarly,clinicalstudiesindicatethatearly
exposure toleadproducesfunctionallyirreversibledamagetotheCNS;experimentalresearchdemonstrates
thatthisirreversibility mayinvolvefailuretoremoveleadfrombrain, permanenteffectsonsynaptogenesis;
and chelant-induced redistribution of lead from the periphery to the CNS. Lead toxicokinetics demand
reevaluation. Newdataonreleaseofbonestoresofleadduringphysiologicalconditionsofdemineralization
indicatethatmobilizationofboneleadaddstoinuteroexposureofthefetus. Furthermore, postmenopausal
demineralization of bone can increase blood lead levels in women by 25%; this raises concern about the
potential effects oflead in an aging population andthe difficulties incomprehensive exposure assessment.
Introduction
There is considerable merit, but also some shame, to
basing a discussion of subtle effects of environmental
agents onhumanhealthinthe context ofourend-of-the-
century knowledge of lead poisoning. The merit lies in
theadvancesofbasicandclinicalresearchduringthelast
twodecades thatamplydemonstrate the progress made
in considering an important disease entity in its less
overt, subclinical, subtle, andfinallymechanistic terms.
The shame arises from realizing that we are grounding
this discussion with its implications for the future of
toxicology and environmental health in considering a
poison having human health effects that have been rec-
ognized, varyingly since the second century B.C.
Thepremise ofthis paperisthatthe elucidation ofthe
low-level effects oflead has been a source ofimportant
and far-reaching answers to critical questions such as
thereversibility andthe dose responsefortheseeffects.
This progress has equally used the results of clinical,
epidemiological, and basic research. Basic research has
provided the mechanistic information that is used to
base hypotheses for the relationship between dose and
effectforleadatlowdoseandforpredictingthepotential
reversibility ofthese low-level effects when exposure is
reduced.
Dose Response
From the seminal epidemiological studies by Needle-
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man et al. (1), now replicated by many other investiga-
tors around the world, data have been derived that are
consistentwithahypothesisthatthedeficitsobservedin
youngchildren with increased lead absorption are with-
out threshold. That is, in the comprehensive behavioral
evaluations done by Needleman and Yule (2), the re-
lationship betweendentinelead, amarkerofcumulative
lead dose, andincreased incidence ofproblembehaviors
seemed smooth, from the lowest concentrations oflead
inteeththroughthehighest. This suggestionofalackof
a detectable threshold was strengthened by the data
from England (3), where, for a variety ofreasons, lead
exposureisgenerallylower. Thechildren inthe English
studiescouldbecombinedwiththoseinthe U.S. studies
to extend the overall dose-response curve lower, as
Needlemanandothershavedonewithmeta-analysis(1).
In discussions ofthreshold, which frequently become
theoretical rather than empirical, as Patterson has
pointed out, no population in this era can be considered
true controls forlead because all postindustrialhumans
have greatly increased body burdens of lead, as com-
pared to pre-industrial populations (4). Thus, while
theoretically there may be athreshold forthe biological
effects oflead (if absolutely lead-free systems could be
compared tothose with verylow-level exposures)inthe
context of generalized lead contamination and even of
experimental systems such as cell cultures, it is more
relevant to determine whether or not there are non-
monotonic regions ofthe empirical dose-response curve
between controls and exposed populations or systems.
In such circumstances, even with the general ex-
posure ofso-called controls, itis stillpossible toobserveE. K. SILBERGELD
andtorationalize thresholds forendpoints inlead toxic-
ity. In arecent analysis ofdataby Schwartz etal. (5) on
peripheralneurotoxicityinchildren exposed tolead, we
found that the available data on nerve conduction ve-
locity are best fit by a quadratic, nonlinear function,
suggestingthatathresholdmayexistforthistoxiceffect
(5). This threshold may result from the mechanisms
involved in neurotoxicity, such as the need to recruit
severalnervefibersintoadysfunctionalstateinorderto
produce biologically significant or detectable de-
crements in compound nerve action potentials. Con-
versely, for central nervous system (CNS) toxicity, this
threshold does not appear to occur.
When considering how lead could produce neurotoxic
effects in the CNS with no empirically observable
threshold, the most likely candidate for such a mech-
anism is the ionic nature of lead as a neurotoxin. The
hypothesis that lead might interfere with ions that are
essential to supporting chemical neurotransmission is
based on experimental studies using different neuronal
preparations. At the neuromuscularjunction, there are
clear lead/calcium interactions that are consistent with
anantagonismbetweenthetwocationsintheregulation
of stimulation-dependent transmitter release. How-
ever, the unstimulated miniature endplate potentials
(MEPPs) release ofneurotransmitter atperipheralcho-
linergicjunctions was actually increased by lead. These
findingsindicatedthattheinteractionsbetweenleadand
calcium were likely to be complex (6).
In the central nervous system, in vitro lead exposure
to brain cells (neurons and capillary epithelial cells)
resulted in increased transmembrane calcium influx. In
synaptosomes, which are pinched off nerve terminals
prepared fromratbrain, thisincreasedinfluxofcalcium
appeared to reflect altered calciumfluxes atthe level of
mitochondria (6,7). When synaptosomes were prepared
as ghosts (resealed membranes), the lead-induced in-
crease in transmembrane calcium influx was abolished
(Table 1) (8). A similar conclusion was reached by
Pounds (9) studying hepatocytes in culture. Pounds
stated that lead affected adeep compartment ofcalcium
regulation that was probably mitochondrial, and it
caused an overall increase in the uptake of calcium by
thesecells, particularlyunderconditionsthatstimulated
their activity (e.g., insulin).
Table 1. 'Ca uptake and binding by synaptosomes, membranes,
and synaptosomal ghosts.
45Ca bound, ng-atoms/mg protein/4 mina
Lead concentration
Fraction 0 10-8 1O-7 10-6 1i-5
Synatosomes 65.0 72.3 80.9* 89.1* 145.2*
Synaptic
membranes 5.1 4.9 5.6 8.2 3.0
Synaptosomal
ghosts 6.6 5.8 5.4 7.8 4.5
aAliquots offractions were incubated for4 min at 37°C with Pb and
'CaCl2 (2-7 x 10i cpm). Results aremeansforsixexperiments, each
done in triplicate.
*Significantly different from [Pb] = 0, p < 0.05.
Figure 1 shows schematically how a mitochondrial
mechanism might result in altered transmitter release.
As confirmed by X-ray microprobe analysis, nerve ter-
minals preferentially sequester lead in mitochondria.
These lead-exposed mitochondria also contain, qualita-
tively, more calcium than do control synaptosomes (10).
Lead-containing mitochondria are refractory to the ac-
tion of sodium to promote the efflux of bound calcium
into the cytosol. The sodium-dependent release ofmito-
chondrially bound calciumis amajorintracellularmech-
anism for regulating the concentration ofcytosolic free
[Ca2'] in excitable cells. The release ofstored calcium,
bysodium, oneoftheioniccarriersofalteredmembrane
potential, acts to decrease the voltage-dependent influx
of calcium that follows membrane depolarization in
nervecells(7). Bydecreasingthisintracellularrelease of
storedcalcium, thetransmembrane gradientforcalcium
remainshigh, andrelativelymorecalciumentersthecell
when membrane pores are open. This transmembrane
flux ofcalcium appears to be critical for depolarization-
coupled transmitter release.
These effectsappeartoinvolvemolecularinteractions
NERVE TERMINAL
Na+
MECHANISM OF PB++ INTERFERENCE
IN INTRATERMINAL CA++ MOVEMENT
FIGURE 1. Schematic represention ofthe mechanism ofaction oflead
toaltersodium-calciuminteractionsresultinginincreasedreleaseof
vesicle-bound transmitter. Lead is storedinmitochondria, inproxi-
mityto Ca2+ (possibly atthe same site, aCa2e+Mg2+ ATP). Inthis
molecular complex, Ca2+ is less releasable on voltage-dependent
increases in intracellular Na+ (shown entering the cell through a
sodium pore). As aconsequence, concentrations offree Ca2+ in the
cytosol are unbuffered by mitochondrial Ca2+, and the transmem-
brane gradient for Ca2+ is augmented. This results in increased
influx ofCa2+ across the membrane under conditions where Ca2+
channels areopened(depolarization); theinfluxofCa2'isassociated
with increased rates of vesicle adhesion to the presynaptic mem-
brane-active zone aswell as increased rates ofvesicularexocytosis.
See Silbergeld and Adler (1) for details.
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among lead, calcium, and sodium. Although the exact
stoichiometry amongtheseions atthecriticalsite (prob-
ably an ATPase inmitochondria) (8) is notyetknown, it
is plausible to hypothesize that it is on a mole-for-mole
basis. Thus mechanistically, the basic research about
lead supports the strong indications in epidemiological
literature that low-level lead exposure is practically
without a threshold (over the ranges that are currently
encountered.)
Interest in lead-calcium interactions is not restricted
to neurotoxicity, although this has been the major area
ofinterest. Withthefindingthatlow-levelleadexposure
mayalso affectgrowthand stature (11)thereisgrowing
concern about the effects of lead on calcium status re-
lated tobone. Recentexperimental studies onbonecells
in culture confirm that bone cell calcium metabolism is
also affected bylead atlowconcentrations (12). Thisis a
subject which will be discussed further, but the lessons
of lead-calcium interactions in ionic mechanisms of
neurotransmission may be useful to keep in mind while
these new areas ofcalcium-dependent lead toxicity are
explored.
Mechanisms of Irreversibility
In evaluating the significance of relatively low-level
leadexposure, thepotentialforreversingtheseeffectsis
ofmajorconcern, particularlyinyoungchildrenexposed
prenatally or postnatally. Early detection and inter-
vention might alter the course ofdysfunction for these
children. This has been explored in mechanistic as well
as descriptive experiments. Descriptively, there are a
numberofstudiesthathavefoundpersistentneurotoxic
effects in animal models. However, the nature ofthese
effects and the neurochemical substrate for them are
important components to understanding reversibility.
Early clinical descriptions ofthe consequences oflead
exposure in young children referred to a certain con-
stellation of neurobehavioral disorders with varying
components ofwhat has been called minimal brain dys-
function (MBD), attention deficit disorder (ADD), or
hyperactivity. While, at times, there has perhaps been
overemphasis on exact homologies between the rela-
tively undefined clinical entity and models produced in
animals, the concept has been useful in suggesting
critical experiments.
A monoaminergic hypothesis has been proposed for
many ofthe symptoms of MBD/ADD (13). The clinical
use of the stimulants methylphenidate and d-ampheta-
mine has also been cited as a basis for this biochemical
hypothesis: basically, that monoaminergic systems are
dysfunctional in these children (14). Although critical
tests ofthis hypothesis have been inconclusive (largely
because of barriers to detecting the status of chemical
neurotransmission in the brain without invasive tech-
niques), this hypothesis is consistent with the larger
aminergic hypothesis of mental dysfunction and major
affective diso,rders.
The demonstration thatlead-exposed rodents, hyper-
active or not, had abnormal dose-response curves for
stimulants (15,16) provoked considerable exporation of
monoaminergic function in lead-exposed animals.
As summarized by Winder and Kitchen (17), these
studieshave notbeenentirelyconsistent. However, the
preponderance ofrecentstudieshavefoundevidencefor
the increased release ofdopamine in lead-exposed ani-
mals (decreased levels of transmitter, increased turn-
over, increased concentrations of metabolites). While
these effects probably do not explain all the clinical
findings associated with low-level lead exposure, they
haveprovided apotentialmarkerforleadneurotoxicity.
AsshowninFigure2, wehaveexploredthefunctional
status of monoaminergic function in lead-exposed chil-
dren by measuring urinary metabolites collected in
quantitative 24-hr urine samples (18,19). Both homo-
vanillic acid (HVA) and vanillylmandelic acid (VMA)
were measured by standard fluorometric techniques.
However, VMA appeared to be less stable; thus our
analyseshavefocused onHVA. IncreasedlevelsofHVA
were associated with increased blood lead in these chil-
dren and had statistical significance. The association of
this biochemical markerwith neurologic status or other
indices of lead toxicity is not known. However, this
effect appears independent of lead activity on heme
synthesis, because there was very poor correlation be-
tween HVA and urinary aminolevulinic acid (ALA), or
erythrocyte protoporphyrin-two markers of heme
synthesisused todiagnose lead exposure (19). Levels of
urinary HVA were also studied in a group of children
who underwent chelation therapy for excessive lead
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FIGURE 2. Blood lead (PbB) levels and urinary homovanillic acid
(HVA)in 11children, measuredbefore(solidcircles)andafter(open
circles) chelation therapy. The shaded area indicates the range of
control values for urinary HVA in children. See Chisolm and Sil-
bergeld (19) for details.
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exposure. This treatment was effective at lowering
blood lead levels, as shown in Figure 2. Also, levels of
HVA were alsoreduced inthe children aftertreatment.
However, it is important to note that even with exten-
sive chelation (EDTA and penicillamine) and extensive
excretionofleadinurine, monitoredovertreatment, the
levels of urinary HVA in many of these children still
remained elevated, whencomparedtocontrols(Chisolm
and Silbergeld, unpublished data).
The elevated urinary HVA may reflect any of the
following phenomena: first, chelation was unsuccessful
at lowering concentrations oflead in the brain; second,
thatthe lead-induced damage to catecholaminergic neu-
rochemistry was not reversed by removing lead; and
third, that chelation actually increased brain lead ex-
posure, at least in the relatively short-term period fol-
lowing therapy by transferring lead from bone and pe-
ripheral soft tissue stores back to theblood and recircu-
lating it to the brain.
Experimental evidence suggests that chelation using
EDTAisnotparticularlyeffectiveatloweringbrainlead
concentrations. Therefore, the simplest explanation of
the observed persistence ofelevated urinary HVA may
becorrect, thatleadremainsinsituto alterthemetabo-
lism of dopamine. The second alternative may also be
correct. Ifleadexposureoccurredduringcriticalperiods
of synaptogenesis and chemical linkages within neural
networks, then early exposure might result in fixed
damage. The third hypothesis that treatment might
exacerbate lead neurotoxicity is being explored at the
presenttime. Ourstudiesinvitrofoundthattheaddition
of a powerful sulfhydryl chelator, dithiothreitol, could
prevent lead effects only when added before lead, not
after (7). This also suggested that intraorgan and intra-
cellular lead is difficult to remove. The slow turnover of
brain components results in the relative fixation oflead
at the target site long after external sources are re-
duced.
Insummary, theaminergichypothesishasbeenuseful
forexperimental research onthe neurochemical basis of
lead toxicity. Moreover, the involvement ofthis system
is, atleast, broadly consistent with some ofthe features
ofneurobehavioral pathology described in clinical popu-
lations. And finally, the hypothesis that lead-induced
deficits might not be reversible may involve poorly
reversible lesions ofcatecholaminergic pathways in the
brain. Theseirreversible deficits are mostclearlyshown
in some of the newer long-term prospective studies of
children exposed originally in utero.
Alternative Mechanisms for Lead
Neurotoxicity
Itiswellknownthatleadisapotentdisrupterofheme
synthesis (20). Lead acts to inhibit the rate-limiting
enzyme ALA dehydrase (ALAD), and probably also
reduces activity ofheme oxygenase and ferrochelatase.
Because of the feedback mechanisms in this pathway,
lead-induced inhibition ofALAD is associated with de-
pression and overactivity ofALA synthase (ALAS) and
porphobilinogen (PBG) deaminase. As a consequence,
levels ofALAandPBGgreatlyincreaseinlead-exposed
persons.
Theroleofthesebiochemical effectsinleadtoxicityis
notknown. AsshowninFigure3, itcanbehypothesized
thatdepletingcriticalstoresofhememightaffectawide
range of enzyme and cytochrome systems. Moreover,
the overproduction ofALA and PBGmightitselfcreate
toxiceffectsifthesetwomoleculesarethemselvesbioac-
tive. The analyses ofneurotoxicity in workers exposed
to lead, which incorporate markers of heme synthesis,
provide further explanation of the dose-relatedness of
these effects over and above that conferred by cor-
relations based on blood lead levels alone. Two recent
reviewshave examined howlead-included alterations in
heme synthesis might result in neurotoxic signs and
symptoms (22,23): lead may deplete heme for critical
oxidative pathways including cytochromes that carry
intracellular oxygen; altered heme synthesis may de-
prive gliaofcritical components and resultinthefailure
of normal neuronal-glial interactions involved in the
supply of precursors for neurotransmitters; altered
heme synthesis may have an impact on two amino acids
knowntobeinvolvedinneurotransmission, glycine (the
precursor to ALA) and serotonin (24); and certain heme
precursors that accumulate in abnormally high con-
centrations may be neurotoxic. Considerable attention
Increased heme precursors (ALA) Reduced heme
Reduced -- Anemia-reduced
hemogloin oxygen transport
synthesis to all tissues
Effects on neuronE
axons, and schwa
interactions with Reduced -4 Impaired cellular Impaired
Na-K, ATPase -hemoproteins energetics myelinati
II \ and nerv(
Interaction with
synaptic receptors
for GABA I N
IS-
ann cells
ion
fe
conduction
Impaired
development
of nervous
system
Disturbed - Impaired mineral
regulatory role tissue homeostasis
ofcalcium m .
Reduced 1,25 (OH)2 -0 Disturbed calium - Impaired calcium
vitamin D metaboism rote assecond
messenger
Impaired calcium role
-0 Impaired in neurotransmission
detoxification
of xenobiotics - 0 Impaired detoxification
of environmental toxins
Impaired Detoxification
for drugs
IL 01 Impaired metaboism -O Reduced-hemefor heme
of endogenous regulated transformations
agonists
FIGURE 3. Summary of biological effects of lead associated with
altered heme synthesis.
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has been given to the biological activity ofALA, which
structurallyresembles -y-aminobutyricacid(GABA)and
has been shown to displace GABA from synaptic mem-
brane receptors (22). Recently, it has been proposed
that PBG may displace benzodiazepines from mit-
ochondrial membrane receptors in peripheral organs
(25). It is also of interest to examine the structure of
PBG and compare it to other pyrrole and pyrrolelike
structures. Of particular interest is the similarity be-
tween PBG and the well-known neurotoxin kainic acid
(26). We attempted to inject PBG into the basal ganglia
of rats to determine ifit has excitotoxin-like activities;
however, to date, we are not certain that we have been
able to adequately solubilize or protect this molecule in
order to deliver a relevant pharmacological dose to po-
tentially sensitive cells (Schwartz and Silbergeld, un-
published observation).
Consideration of the possible mechanistic role of
altered heme synthesis in lead toxicity is important for
two reasons: first, there is evidence (27) for genetic
heterogeneity in the sensitivity of a critical enzymic
target for lead in this pathway, ALAD, which may
confer interindividual differences in susceptibility; sec-
ond, alterations in heme synthesis are an outcome of
many other chemical exposures, notably the halo-
genated hydrocarbons; like lead, some of these hydro-
carbons have figured in episodes of significant human
exposure and alleged health effects. The establishment
ofsensitive markers forthe early effects ofthese agents
might assist in refining clinical and experimental stud-
ies. Thesemarkersmightalsoprovidebasesformechan-
istic hypotheses for actions, thresholds, and rever-
sibility questions similar to those that have arisen with
lead.
Newer Thoughts on Reversibility:
Lead Toxicokinetics
The apparent irreversibility of lead toxicity, which
has been reported in two of the long-term prospective
studies in children, may result from one of two mech-
anisms: failure of affected systems to recover (fixed,
noncompensible damage), or the persistent presence of
lead atthetargetsite. Eithermechanismwouldindicate
thatleadtoxicityispoorlytreatable andbestprevented.
In addition, the long-term toxicokinetics of lead are
only beginning to be examined. It is well known that
most ofthe absorbed lead is stored in bone, which has a
longturnoverrate and eventually contains about 95% of
the body burden oflead. In general, little attention has
been paid to this compartment orto the storage oflead.
It is considered to be a sequestration orremoval oflead
from active sites in soft tissues. This may not be true.
The kinetics of bone lead may add to the reversibility
problem forlead-exposed persons by providing a cumu-
lative store that may release its contents under certain
stresses orphysiologicalchanges. Datainhumansisonly
beginning to be examined. Studies of lead kinetics in
pregnant women are contradictory and confounded by
the complexity ofcompartments for analysis (28). Barl-
trop's pioneering studies suggest that maternal lead
stores are released over pregnancy, accounting for the
dramatic increases in bone and soft tissue lead con-
centrations in the fetus over gestation.
We have examined blood lead levels in postmeno-
pausal women, who compose another population where
changes in bone physiology occur in response to the
hormonal changes associated with loss of reproductive
capacity (29). In approximately 15% ofpostmenopausal
women, osteoporosis (clinical bone demineralization)
occurs, representing a substantial and rapid loss ofmin-
eral from bone (30). We used the NHANES II dataset
(31) and examined blood lead in 800 postmenopausal
women, bothblack(126)andwhite. AsshowninTable2,
postmenopausal women had significantly higher blood
lead levels than premenopausal women; this increase
was significant even when covariates were considered
(diet, exercise, smoking, weight). Interestingly, the
increaseinbloodlead wasmuchgreaterinwhitesthanin
blacks, although in terms of absolute value, blood lead
levels were as expected higher in black women. More-
over, the data indicated that mobilization of bone lead
probably also occurred in this population with preg-
nancy. That is, in the postmenopausal sample of women
who had been pregnant, the postmenopausal increase
was less than in those women who had never been
pregnant; this was found in both blacks and whites, but
again more predominantly in whites. The results thus
suggestthatbonelead is stored cumulatively, reflecting
long-term exposure and deposition. However, stored
bone lead can be mobilized and cause rapid changes in
internal exposure under fairly standard conditions.
There are several implications of this new aspect of
lead toxicokinetics: First, during pregnancy, mobil-
ization ofbone lead in the mother probably contributes
toinutero exposure, alongwiththemother'sconcurrent
external dose from the environment or her occupation.
One lessonis thatevaluation ofthemotheratthe time of
pregnancy may not be sufficient to predict exposure of
the fetus and neonate. Already, one case has been re-
Table 2. Effect of menopause and prior pregnancy on blood and plasma lead levels in women.
All women White Black
Change in blood lead mcg/dL % Change mcg/dL % Change mcg/dL % Change
Pre/postmenopause 1.47 12.6 1.67 14.7 0.62 4.6%
Pre/postmenopause, 2.56 22.0 2.67 23.4 1.31 9.8
never pregnant
Pre/postmenopause, 1.37 11.8 1.45 12.7 0.50 3.7
ever pregnant
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ported regarding a woman, intoxicated with lead as a
child, becomingreintoxicated andgivingbirth toababy
withveryhighblood leadas aconsequence ofthismobil-
ization (32).
Second, the results raise questions as to the impor-
tance of examining the aging population as a group
potentially at risk for lead toxicity, based on accumu-
lated body burden lead being released over a relatively
short period of time. (Postmenopausal osteoporosis
occurs primarily within the first 5 years postmenses.)
The relatively large increase in blood lead that might
thenoccurrepresents amuchgreaterdose-ratethanthe
increase that may have occurred over the years oflow-
level exposure to external sources oflead inthe general
environment. Given new knowledge as to the low-level
effects oflead, itisnotunreasonable to considersome of
thefollowingaspotentialoutcomesofsuchexposurelate
in life: increased risk ofhypertensive heart disease and
renal disease; neurotoxicity, including dementing dis-
orders ofthe elderly; and osteoporosis itself(29). These
studies need to be conducted as we continue to follow
lead as atoxin ofcritical environmental significance and
public health importance into the twenty-first century.
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